Tags: Drug.

Siltuximab (INN) (also known as Sylvant CNTO 328 Anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6. Siltuximab has been investigated for the treatment of metastatic renal cell cancer prostate cancer and Castleman’s disease among other types of cancer.It has undergone a phase I clinical trial in patients With B-cell non-Hodgkin’s lymphoma multiple myeloma or Castleman’s disease.

ATC prefix
none
CAS number
541502-14-1
FDA UNII code
T4H8FMA7IM

Loading...

This page contains content from the copyrighted Wikipedia article "Siltuximab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.